Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 4:58 PM View:  | Hakim Nasrat A CEO, President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 29-Mar-24 | Grant | 49,534,400 | -- | -- | 29% 172.04M to 221.57M | |
| 29-Dec-23 2:21 PM View: | Hakim Nasrat A CEO & President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 29-Dec-23 | Grant | 2,223,150 | $0.07 | $153,397.00 | 1% 160.72M to 162.94M | |
| 27-Nov-23 6:50 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 22-Nov-23 | Grant | 547,657 | $0.04 | $19,989.50 | 20% 2.69M to 3.24M | |
| 27-Nov-23 7:05 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 22-Nov-23 | Grant | 547,657 | $0.04 | $19,989.50 | 21% 2.64M to 3.19M | |
| 27-Nov-23 6:58 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 22-Nov-23 | Grant | 547,657 | $0.04 | $19,989.50 | 36% 1.5M to 2.05M | |
| 29-Aug-22 1:49 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 28-Aug-22 | Grant | 459,536 | $0.04 | $19,989.80 | 21% 2.18M to 2.64M | |
| 29-Aug-22 1:40 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 28-Aug-22 | Grant | 459,536 | $0.04 | $19,989.80 | 44% 1.04M to 1.5M | |
| 29-Aug-22 1:35 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 28-Aug-22 | Grant | 459,536 | $0.04 | $19,989.80 | 21% 2.23M to 2.69M | |
| 01-Jul-21 6:30 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 30-Jun-21 | Grant | 295,570 | $0.07 | $20,010.10 | 40% 746.67K to 1.04M | |
| 01-Jul-21 6:36 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 30-Jun-21 | Grant | 295,570 | $0.07 | $20,010.10 | 16% 1.88M to 2.18M | |
| 26-Aug-20 1:29 PM View: | Hakim Nasrat A CEO & President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 24-Aug-20 | Conversion | 158,016,992 | -- | -- | 1339% 11.8M to 169.82M | |
| 24-Aug-20 2:11 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 20-Aug-20 | Grant | 516,781 | $0.09 | $45,011.60 | 37% 1.42M to 1.93M | |
| 24-Aug-20 2:24 PM View: | Plassche Douglas SVP Operations | Elite Pharmaceuticals Inc. (ELTP) | 20-Aug-20 | Grant | 71,739 | $0.09 | $6,284.34 | 7% 1.06M to 1.13M | |
| 24-Aug-20 2:15 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 20-Aug-20 | Grant | 516,781 | $0.09 | $45,011.60 | 38% 1.37M to 1.88M | |
| 24-Aug-20 2:18 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 20-Aug-20 | Grant | 516,781 | $0.09 | $45,011.60 | 225% 229.89K to 746.67K | |
| 06-Jul-20 11:38 AM View: | Plassche Douglas SVP of Operations | Elite Pharmaceuticals Inc. (ELTP) | 30-Jun-20 | Grant | 574,597 | $0.09 | $49,989.90 | 118% 487.59K to 1.06M | |
| 27-Feb-18 4:59 PM View: | Ward Carter Julian CFO, Sec., Treas. | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 242,060 | $0.12 | $29,991.20 | 7% 3.24M to 3.48M | |
| 27-Feb-18 5:15 PM View: | Pfeifer Eugene M Director | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 161,374 | $0.12 | $19,994.20 | 224% 72.04K to 233.41K | |
| 27-Feb-18 4:53 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 161,374 | $0.12 | $19,994.20 | 13% 1.21M to 1.37M | |
| 27-Feb-18 5:02 PM View: | Plassche Douglas SVP of Operations | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 201,717 | $0.12 | $24,992.70 | 71% 285.88K to 487.6K | |
| 27-Feb-18 4:37 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 161,374 | $0.12 | $19,994.20 | 236% 68.52K to 229.89K | |
| 27-Feb-18 4:42 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 161,374 | $0.12 | $19,994.20 | 13% 1.25M to 1.42M | |
| 03-May-17 6:17 PM View: | Hakim Nasrat A CEO & President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 28-Apr-17 | Disposition (other) | 158,016,992 | -- | -- | (93%) 169.81M to 11.8M | |
| 27-Feb-17 6:59 PM View: | Caskey Davis S Director | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 68,518 | $0.20 | $13,443.20 | 100% 0 to 68.52K | |
| 27-Feb-17 6:09 PM View: | Hakim Nasrat A CEO & President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 2,216,990 | $0.23 | $499,932.00 | 1% 167.6M to 169.82M | |
| 27-Feb-17 6:17 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 88,679 | $0.23 | $19,997.10 | 8% 1.17M to 1.25M | |
| 27-Feb-17 6:41 PM View: | Ward Carter Julian Director | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 133,019 | $0.23 | $29,995.80 | 4% 3.11M to 3.24M | |
| 27-Feb-17 7:08 PM View: | Pfeifer Eugene M Director | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 72,040 | $0.20 | $14,588.10 | 100% 0 to 72.04K | |
| 27-Feb-17 6:26 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 88,679 | $0.23 | $19,997.10 | 8% 1.12M to 1.21M | |
| 27-Feb-17 6:46 PM View: | Plassche Douglas SVP of Operations | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 110,849 | $0.23 | $24,996.40 | 63% 175.03K to 285.88K | |
| 19-Aug-16 10:00 PM View: | Hakim Nasrat A CEO & President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 17-Aug-16 | Option Exercise | 142,856,992 | -- | -- | 577% 24.74M to 167.6M | |
| 03-May-16 11:50 AM View: | Ward Carter Julian CFO, Secretary, Treasurer | Elite Pharmaceuticals Inc. (ELTP) | 28-Apr-16 | Conversion | 666,667 | $0.06 | $41,666.70 | 27% 2.44M to 3.11M | |
| 15-Apr-16 3:13 PM View: | Narine Jeenarine | Elite Pharmaceuticals Inc. (ELTP) | 13-Apr-16 | Conversion | 4,000,000 | $0.06 | $250,000.00 | 31% 12.74M to 16.74M | |
| 21-Mar-16 5:06 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 18-Mar-16 | Market Sale | 258,090 | $0.34 | $88,266.80 | (3%) 7.9M to 7.64M | 56% |
| 21-Mar-16 5:06 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 17-Mar-16 | Market Sale | 312,430 | $0.34 | $107,788.00 | (4%) 8.21M to 7.9M | 57% |
| 24-Feb-16 4:57 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 24-Feb-16 | Market Sale | 100,456 | $0.31 | $31,141.40 | (1%) 8.31M to 8.21M | 57% |
| 24-Feb-16 4:57 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 22-Feb-16 | Market Sale | 100,000 | $0.32 | $32,090.00 | (1%) 8.41M to 8.31M | 59% |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 17-Feb-16 | Market Sale | 50,000 | $0.31 | $15,580.00 | (< 1%) 8.46M to 8.41M | 52% |
| 18-Feb-16 7:05 PM View: | Hakim Nasrat A Chairman, CEO, President Director 10% Owner | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 2,854,280 | $0.25 | $699,869.00 | 13% 21.89M to 24.74M | |
| 18-Feb-16 7:26 PM View: | Plassche Douglas Exec Vice Pres Operations | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 47,767 | $0.26 | $12,500.60 | 38% 127.26K to 175.03K | |
| 18-Feb-16 7:01 PM View: | Whitnell Jeffrey A Director | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 81,549 | $0.25 | $20,004.00 | 8% 1.04M to 1.12M | |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 124,646 | $0.25 | $30,899.70 | 1% 8.34M to 8.46M | |
| 18-Feb-16 6:56 PM View: | Ward Carter Julian CFO, Sec., Treas | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 122,325 | $0.25 | $29,994.10 | 5% 2.32M to 2.44M | |
| 18-Feb-16 6:44 PM View: | Narine Jeenarine Director | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 81,549 | $0.25 | $20,004.00 | < 1% 12.66M to 12.74M | |
| 18-Feb-16 6:29 PM View: | Dash Barry H Director | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 81,549 | $0.25 | $20,004.00 | 8% 1.08M to 1.17M | |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 05-Feb-16 | Market Sale | 24,400 | $0.33 | $8,052.00 | (< 1%) 8.36M to 8.34M | 55% |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 04-Feb-16 | Market Sale | 349,660 | $0.32 | $111,891.00 | (4%) 8.71M to 8.36M | 53% |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 03-Feb-16 | Market Sale | 45,518 | $0.33 | $15,020.90 | (< 1%) 8.76M to 8.71M | 52% |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 02-Feb-16 | Market Sale | 13,000 | $0.33 | $4,290.00 | (< 1%) 8.77M to 8.76M | 52% |
| 18-Feb-16 7:49 PM View: | Treppel Jerry | Elite Pharmaceuticals Inc. (ELTP) | 01-Feb-16 | Market Sale | 312,300 | $0.34 | $106,182.00 | (3%) 9.08M to 8.77M | 54% |
